Roche Survey Finds 61% Mental Burden, 80% Demand Predictive Glucose Tools
A global survey of 4,326 people with diabetes across 22 countries found 61% report daily unpredictability and mental burden in managing glucose levels, with 80% valuing predictive glucose monitoring tools. Over 11% of adults currently live with diabetes, rising by 46% to one in eight adults by 2050, underscoring demand for advanced management solutions.
1. Survey Highlights Daily Burden
The global survey of 4,326 individuals across 22 countries reveals that 61% feel daily mental strain managing blood glucose, with unpredictable readings interfering in work, childcare, sports and travel. A majority struggle with planning around meals and medication schedules, with 71% of Type 1 patients reporting heightened anxiety about their days.
2. Demand for Predictive Tools
Eight in ten respondents said they would value tools that forecast glucose changes before they occur, and 46% believe early trend insights would give them greater control. This preference signals strong user interest in next-generation continuous glucose monitoring devices offering predictive algorithms rather than solely real-time data.
3. Market Growth Projections
Currently over 11% of adults aged 20–79 live with diabetes, while four in ten remain undiagnosed. By 2050, prevalence is expected to rise by 46%, affecting roughly 853 million adults worldwide, highlighting an expanding addressable market for innovative diabetes management technologies.
4. Implications for Roche
Findings underscore a clear opportunity for Roche Diagnostics to accelerate development of predictive continuous glucose monitoring systems that provide actionable forecasts. Successfully commercializing such solutions could strengthen Roche’s diagnostics franchise, drive revenue growth and enhance competitive positioning in a rapidly expanding diabetes care market.